Grant opportunity
Framework Contracts for Next Generation Therapeutics for Infectious Diseases
Upcoming EU4Health call for tenders to speed development and access to next-generation therapeutics for infectious diseases through pre-commercial procurement.
- Funder
- European Health and Digital Executive Agency / HERA
- Upcoming tender deadline
- Upcoming tender deadline: Jul 3, 2026
- Award
- Indicative budget EUR 244 million
- Applicant
- Organizations & NGOs
- Discipline
- Health & Biomedical Sciences
- Region
- Europe
- Posted
- May 27, 2026
Call summary
Overview
HaDEA published an upcoming EU4Health call for tenders on framework contracts to accelerate development and access to innovative medical countermeasures, focused on next-generation therapeutics for infectious diseases.
Who can apply
- Interested economic operators and consortia should monitor the official HaDEA page and EU Funding and Tenders Portal for the full tender documents.
- Applicants should confirm procurement eligibility, tender requirements and consortium rules once the contract notice is published.
What it supports
- Pre-commercial procurement for promising next-generation therapeutics for infectious diseases.
- Development of innovative therapeutics for viral infections, acute respiratory distress syndrome or sepsis resulting from infections.
- Health preparedness, medical countermeasures and EU4Health objectives.
Funding and duration
Indicative budget is EUR 244 million.
Upcoming tender deadline
Upcoming tender deadline: Jul 3, 2026
How to apply
Monitor the official HaDEA call page and EU Funding and Tenders Portal for the full tender package and submit by the listed 3 July 2026 deadline once the call is open.
Call details
HaDEA lists this call as upcoming, with publication date 27 May 2026 and deadline date 3 July 2026. The tender aims to speed up the development of promising next-generation therapeutics for infectious diseases through competitive development in phases under pre-commercial procurement. The scope is expected to include innovative therapeutics for viral infections, acute respiratory distress syndrome or sepsis resulting from infections, contributing to health emergency preparedness and EU4Health objectives.
Interested economic operators and consortia should monitor the official HaDEA page and EU Funding and Tenders Portal for the full tender documents.
Applicants should confirm procurement eligibility, tender requirements and consortium rules once the contract notice is published.
Pre-commercial procurement for promising next-generation therapeutics for infectious diseases.
Development of innovative therapeutics for viral infections, acute respiratory distress syndrome or sepsis resulting from infections.
Health preparedness, medical countermeasures and EU4Health objectives.
Indicative budget is EUR 244 million.
Upcoming tender deadline: Upcoming tender deadline: Jul 3, 2026.
Confirm the exact deadline time, time zone, and submission route on the official call page.
Plan internal approvals, partner confirmations, budgets, letters, and portal submission before the final deadline.
Monitor the official HaDEA call page and EU Funding and Tenders Portal for the full tender package and submit by the listed 3 July 2026 deadline once the call is open.
Before submitting, check required documents, eligible costs, attachments, page limits, institutional approvals, and whether the opportunity uses an expression of interest, full proposal, registration, or nomination stage.